A U.S. Supreme Court decision this past summer regarding the obligations of the manufacturers of generic drugs regarding labeling and warning the public of adverse side effects may leave many injured by defective drugs without a legal remedy.

Many consumers have heard the reports regarding the causal relationship between Tylenol (generic "acetaminophen") and serious liver injuries including liver failure, but many do not know that long-term use of Tylenol has also been linked to serious damage to the kidneys. McNeil, a subsidiary of Johnson and Johnson, manufactures Tylenol or acetaminophen. Acetaminophen has a well-established history of causing long-term kidney damage and failure. The "PDR Guide to Drug Interactions, Side Effects, and Indications" cites a study published in a 2001 New England Journal of Medicine that reported long-term acetaminophen use was associated with an increased risk of end-stage kidney disease. Approximately 8 to 10 percent of the patients in the study who were on acetaminophen developed end-stage kidney disease.

A study published in the Journal of the American Medical Association indicates that some healthy adults who took the normal dose of Tylenol (Generic: "Acetaminophen") for only two weeks suffered liver damage. Participants in the study were instructed to take Tylenol in accordance with recommended indications on the label. They took 4 grams of Tylenol per day, which is the equivalent of eight extra-strength Tylenol.

One of the most widely used birth control pills Yaz or Yasmin (generic form "Ocella") may cause serious side effects, including blood clots, resulting in a stroke or heart attack as well as gall bladder pancreatitis. Yaz is manufactured by Bayer Healthcare, Inc and has been heavily marketed throughout the United States for treating premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD).